Greg Stahler

Title: The Innovative Contributions of Greg Stahler

Introduction

Greg Stahler is a notable inventor based in Belmont, California. He has made significant contributions to the field of medical technology, particularly in the area of optogenetic therapy. With a total of three patents to his name, Stahler's work is paving the way for advanced treatment methodologies.

Latest Patents

Stahler's latest patents focus on systems and methods for optogenetic therapy. These configurations utilize light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms. One of the key applications is hypertension treatment, which involves anatomically specific and temporally precise modulation of renal plexus activity. The invention encompasses proteins, nucleic acids, vectors, and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. Furthermore, it provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities. This includes the generation or inhibition of electrical spikes in nerve cells and other excitable cells.

Career Highlights

Stahler is currently associated with Circuit Therapeutics, Inc., where he continues to innovate in the field of optogenetics. His work is instrumental in developing therapies that could revolutionize treatment options for various medical conditions.

Collaborations

Stahler collaborates with talented individuals such as Ananya Mitra and Joyce Huang, contributing to a dynamic research environment that fosters innovation.

Conclusion

Greg Stahler's contributions to optogenetic therapy exemplify the intersection of technology and medicine. His innovative patents and collaborative efforts are set to make a lasting impact on medical treatment paradigms.